|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
|
|---|---|---|---|---|
| Total revenues | ||||
| Cost of sales, excluding amortization of intangibles | ||||
| Selling, marketing and administrative | ||||
| Research and development | ||||
| Amortization of intangible assets | ||||
| Restructuring, integration and other charges | ||||
| Goodwill impairment charge | ||||
| Asset impairment charge | ||||
| Other operating expenses | ||||
| Operating (loss) income | ||||
| Interest expense, net | ||||
| Loss on extinguishment of debt | ||||
| Other expense, net | ||||
| Loss before income taxes | ||||
| Provision for (benefit from) income taxes | ||||
| Net loss | ||||
| Basic loss per share | ||||
| Diluted loss per share | ||||
| Weighted-average shares outstanding - basic | ||||
| Weighted-average shares outstanding - diluted |
Loading...
